Providence First Trust CO Abbott Laboratories Transaction History

Providence First Trust CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$108.84 - $128.23 $2.64 Million - $3.11 Million	-24,228 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $1.52 Million - $1.66 Million	14,471 Added 148.31%	24,228 $2.65 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $248,802 - $302,152	-2,715 Reduced 21.77%	9,757 $1.06 Million
Q3 2019 Nov 05, 2019	BUY	$81.84 - $88.74 $83,722 - $90,781	1,023 Added 8.94%	12,472 $1.04 Million
Q2 2019 Jul 31, 2019	BUY	$72.88 - $85.0 $834,403 - $973,165	11,449 New	11,449 $963,000
Q1 2019 May 07, 2019	SELL	$66.22 - $80.06 $2.85 Million - $3.44 Million	-42,963 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $54,283 - $61,495	828 Added 1.97%	42,963 $3.11 Million
Q2 2018 Jul 31, 2018	BUY	$57.57 - $63.54 $98,559 - $108,780	1,712 Added 4.24%	42,135 $2.57 Million
Q1 2018 May 08, 2018	BUY	$56.27 - $63.62 $2.27 Million - $2.57 Million	40,423 New	40,423 $2.42 Million

3,167

1.33B

8.63M

7.19M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Providence First Trust CO, based on Form 13F filings with the SEC.

Stay updated on Providence First Trust CO with notifications on news.